These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22339454)

  • 1. Comments on therapeutic cancer vaccines.
    Vonka V
    Immunotherapy; 2012 Feb; 4(2):133-5. PubMed ID: 22339454
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized cancer vaccines.
    Jain KK
    Expert Opin Biol Ther; 2010 Dec; 10(12):1637-47. PubMed ID: 20979567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Q&A: Evidence presenter. Interview by Marian Turner.
    Palucka K
    Nature; 2013 Dec; 504(7480):S9. PubMed ID: 24352364
    [No Abstract]   [Full Text] [Related]  

  • 4. Generation of dendritic cell-based vaccines for cancer therapy.
    Reinhard G; Märten A; Kiske SM; Feil F; Bieber T; Schmidt-Wolf IG
    Br J Cancer; 2002 May; 86(10):1529-33. PubMed ID: 12085199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell epitope peptide vaccines.
    Elsawa SF; Rodeberg DA; Celis E
    Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
    Shurin MR; Gregory M; Morris JC; Malyguine AM
    Expert Opin Biol Ther; 2010 Nov; 10(11):1539-53. PubMed ID: 20955111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes.
    Markiewicz MA; Kast WM
    Cancer Invest; 2004; 22(3):417-34. PubMed ID: 15493363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-HER2 vaccines: The HER2 immunotargeting future?].
    Ladjemi MZ; Jacot W; Pèlegrin A; Navarro-Teulon I
    Pathol Biol (Paris); 2011 Jun; 59(3):173-82. PubMed ID: 19481373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current state and perspectives of dendritic cell vaccination in cancer immunotherapy.
    Farkas A; Conrad C; Tonel G; Borbenyi Z; Kemeny L; Dobozy A; Nestle FO
    Skin Pharmacol Physiol; 2006; 19(3):124-31. PubMed ID: 16612139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells as vectors for immunotherapy of cancer.
    Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
    Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient expansion of peptide-specific lymphocytes producing IFN-gamma after vaccination with dendritic cells pulsed with MAGE peptides in patients with mage-A1/A3-positive tumors.
    Toungouz M; Libin M; Bulté F; Faid L; Lehmann F; Duriau D; Laporte M; Gangji D; Bruyns C; Lambermont M; Goldman M; Velu T
    J Leukoc Biol; 2001 Jun; 69(6):937-43. PubMed ID: 11404379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells in cancer immunotherapy.
    Schuler G
    Eur J Immunol; 2010 Aug; 40(8):2123-30. PubMed ID: 20853498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.
    Nishiyama T; Tachibana M; Horiguchi Y; Nakamura K; Ikeda Y; Takesako K; Murai M
    Clin Cancer Res; 2001 Jan; 7(1):23-31. PubMed ID: 11205913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic-cell-based cancer vaccines.
    Bubeník J
    Folia Biol (Praha); 1999; 45(3):71-4. PubMed ID: 10730892
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular immunotherapy for cancer: current concepts and clinical perspectives scientific basis and approaches for therapeutic cancer vaccines. Part I.
    Quatan N; Spicer J; Plunkett T; Pandha H
    Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):356-65. PubMed ID: 15341440
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials.
    Mossoba ME; Medin JA
    Expert Rev Vaccines; 2006 Oct; 5(5):717-32. PubMed ID: 17181444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dendritic cells and immunotherapy of liver cancer].
    Cao XT
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):133-4. PubMed ID: 12681054
    [No Abstract]   [Full Text] [Related]  

  • 18. DC-based cancer vaccines: lessons from clinical trials.
    Brody JD; Engleman EG
    Cytotherapy; 2004; 6(2):122-7. PubMed ID: 15203988
    [No Abstract]   [Full Text] [Related]  

  • 19. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D; Appel S
    Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell-based vaccines for the therapy of experimental tumors.
    Pajtasz-Piasecka E; Indrová M
    Immunotherapy; 2010 Mar; 2(2):257-68. PubMed ID: 20635932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.